08/14/2025 4:07 PM | Lipella Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/25/2025 2:14 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/16/2025 3:25 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2025 4:05 PM | Lipella Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/01/2025 8:19 PM | Huang Leaf (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025 5:08 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/09/2025 7:39 PM | Chancellor Michael B (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
04/09/2025 7:43 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
04/09/2025 4:06 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/07/2025 6:16 PM | Kaufman Jonathan H (Reporting) Lipella Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/07/2025 6:20 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
Get the Latest News and Ratings for LIPO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Lipella Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
04/07/2025 5:05 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/04/2025 4:14 PM | Lipella Pharmaceuticals (Filer)
| Form 424B5 | |
04/03/2025 11:15 PM | Lipella Pharmaceuticals (Filer)
| Form EFFECT | |
03/28/2025 5:21 AM | Lipella Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/27/2025 6:56 PM | Lipella Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/19/2025 5:23 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
03/18/2025 4:01 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/17/2025 7:18 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
03/17/2025 7:12 PM | Kaufman Jonathan H (Reporting) Lipella Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:01 PM | Kaufman Jonathan H (Reporting) Lipella Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2025 7:09 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
03/11/2025 4:26 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/24/2025 3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/11/2025 8:28 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/10/2025 4:32 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
02/10/2025 4:35 PM | Chancellor Michael B (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/30/2025 4:27 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/30/2025 4:28 PM | Chancellor Michael B (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/23/2025 5:08 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/23/2025 5:11 PM | Chancellor Michael B (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/17/2025 7:13 PM | Kaufman Jonathan H (Reporting) Lipella Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/17/2025 7:17 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
01/16/2025 5:51 AM | Lipella Pharmaceuticals (Filer)
| Form 424B3 | |
01/15/2025 11:15 PM | Lipella Pharmaceuticals (Filer)
| Form EFFECT | |
01/13/2025 7:42 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/07/2025 4:25 PM | Lipella Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/07/2025 4:28 PM | Lipella Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
01/06/2025 4:25 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2025 8:22 PM | Kaufman Jonathan H (Reporting) Lipella Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2025 8:25 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad) Something big is brewing in Washington.
According to my research, an executive order from President Trump could be just weeks away.
And it holds the potential to trigger one of the most explosive tech booms in US history.
At the center of it all? Robots.
Not the kind that clean your house or pour you coffee.
But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year. This little-known company holds nearly 100 patents and trades for around $7 |
12/30/2024 3:11 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2024 8:28 PM | Kaufman Jonathan H (Reporting) Lipella Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2024 8:31 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SCHEDULE 13D/A | |
12/27/2024 3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/10/2024 8:29 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 4:26 PM | Lipella Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024 4:01 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2024 4:24 PM | Lipella Pharmaceuticals (Filer)
| Form PRE 14A | |
11/01/2024 4:00 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2024 3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2024 4:00 PM | Chancellor Michael B (Filed by) Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
10/17/2024 4:00 PM | Kaufman Jonathan H (Filed by) Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/11/2024 4:10 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |